Compare IDEXX Laboratories, Inc. (IDXX) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Paycom Software Inc — how do they compare? IDEXX Laboratories, Inc. trades at $552.09 (market cap $44.48B), while Paycom Software Inc trades at $144.01 (market cap $6.98B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.4× Paycom Software Inc's market cap, and Paycom Software Inc pays a 1% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | PAYC | |
|---|---|---|
Market Cap | $44.48B | $6.98B |
Sector | Health | Technology |
52-Week High | $766.68 | $238.80 |
52-Week Low | $520.87 | $113.59 |
Enterprise Value | $45.38B | $7.59B |
Dividend Yield | — | 1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Paycom Software (PAYC) trades at $149.71, up 1.2% with a bullish technical signal supported by moving averages. The company shows strong profitability with 22.44% net income margin and 37.15% ROE, though recent Q3 2025 EPS slightly missed expectations. Recent developments include new asset management tool launches and board appointments, while analyst consensus sits at $151 price target with 47% buy ratings.
PAYC presents a balanced investment case with solid fundamentals and moderate valuation (P/E 17.12), though execution risks and competitive pressures in HCM software require monitoring. The stock's proximity to resistance at $152 suggests near-term consolidation potential, while earnings growth remains the key catalyst for further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
